Zheng Yang
Nantong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
APOA1 as a Potential Therapeutic Target and Novel Biomarker in Lung Adenocarcinoma.
Journal: Cell biochemistry and function
Published: August 08, 2025
Understanding blaNDM-1 gene regulation in CRKP infections: toward novel antimicrobial strategies for hospital-acquired pneumonia.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 24, 2023
HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 09, 2023
Signal sequence receptor subunit 3: A novel indicator of immunosuppressive tumor microenvironment and clinical benefits from immunotherapy.
Journal: Cellular signalling
Published: June 11, 2023
UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma.
Journal: Cancer medicine
Published: April 06, 2023
A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.
Journal: International journal of general medicine
Published: November 24, 2021
Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Journal: International immunopharmacology
Published: August 28, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026